Earlier in the day, the stock witnessed a gap down start to the session. The stock quoted a 52-week high price of Rs 1063.75 and a 52-week low of Rs 737.9 on NSE. Around 151276 shares changed hands on the counter till 02:01PM (IST).
The stock opened at Rs 970.0 and has touched an intraday high and low of Rs 974.75 and Rs 961.0 during the session so far. The stock quoted a price-to-earnings (PE) ratio of 10.59, earnings per share (EPS) of Rs 91.05 and price to book value (PB) of 1.44, while the return on equity (ROE) stood at Rs 24.32.
Promoter/ FII Holding
The promoters held 51.83 per cent stake in the company as of July 19, while FII and MF ownerships stood at 25.65 per cent and 9.03 per cent, respectively.
With a market capitalisation of Rs 56516.71 crore, the company operates in the Pharma – Indian industry. For the quarter ended 31-Mar-2021, the company reported consolidated sales of Rs 6079.6 crore, down 6.44 per cent from the previous quarter?s Rs 6498.31 crore and down 1.8 per cent from the same quarter a year ago. The company reported net profit of Rs 801.58 crore for the latest quarter, down 5.68 per cent from the corresponding quarter last year.
The relative strength index (RSI) of the stock stands at 48.82. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold condition when it is below 30. Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a “buy” or “sell” recommendation using a single valuation ratio.